Who
Travis Alvin Thompson
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Bicycle Therapeutics.
In numbers
- Trades disclosed
- 53
- Buys
- 0
- Sells
- 24
- Bought
- $0
- Sold
- $307K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 3 Jul 2023
- Last trade
- 5 Oct 2026
- Last filed
- 6 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 5 Oct 2026filed 6 Oct 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $28279 at $3.57 | filing |
| 2 Oct 2026filed 6 Oct 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $3,099893 at $3.47 | filing |
| 15 Jul 2026filed 17 Jul 2026 | BCYC Bicycle Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
| 15 Jul 2026filed 17 Jul 2026 | BCYC Bicycle Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
| 6 Jul 2026filed 7 Jul 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $448104 at $4.31 | filing |
| 6 Jul 2026filed 7 Jul 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $448104 at $4.31 | filing |
| 2 Jul 2026filed 7 Jul 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $3,497819 at $4.27 | filing |
| 2 Jul 2026filed 7 Jul 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $3,497819 at $4.27 | filing |
| 6 Apr 2026filed 6 Apr 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $515102 at $5.05 | filing |
| 6 Apr 2026filed 6 Apr 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $515102 at $5.05 | filing |
| 2 Apr 2026filed 6 Apr 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $3,923799 at $4.91 | filing |
| 2 Apr 2026filed 6 Apr 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $3,923799 at $4.91 | filing |
| 3 Feb 2026filed 4 Feb 2026 | BCYC Bicycle Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —58,000 at $0.00 | filing |
| 3 Feb 2026filed 4 Feb 2026 | BCYC Bicycle Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —58,000 at $0.00 | filing |
| 5 Jan 2026filed 6 Jan 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $7,1921,115 at $6.45 | filing |
| 5 Jan 2026filed 6 Jan 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $7,1921,115 at $6.45 | filing |
| 2 Jan 2026filed 6 Jan 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Code A | —37,500 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $8,9561,317 at $6.80 | filing |
| 2 Jan 2026filed 6 Jan 2026 | BCYC Bicycle Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | BCYC Bicycle Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.